Aquatic Animal Muscle Toxicity Assay Service
Call Us Now:
Talk To Us:
BioVenic offers standardized muscle toxicity testing services, delivering precise targeted data for aquatic ecological safety evaluation, drug toxicological verification and muscle physiological mechanism research. Aquatic muscle toxicity assays are specialized detection techniques that assess skeletal and cardiac muscle damage induced by exogenous compounds in aquatic animals. Environmental pollutants, pharmaceutical agents and aquaculture chemicals may trigger muscle fiber rupture, atrophy, dysplasia and motor dysfunction, which can be accurately identified through this targeted testing system.
Fig 1. Zebrafish model for the study of toxicants affecting muscle. 1,3
Applicable Scenarios: Short-term high-concentration muscular toxicity risk screening. Suitable for rapid evaluation of acute muscle damage and poisoning symptoms caused by sudden exposure of aquatic organisms to chemical compounds and pollutants.
Technical Capabilities: Adopt zebrafish and other short-cycle aquatic models, set multi-gradient acute exposure groups, real-time monitor poisoning symptoms, muscle movement disorders and individual death conditions within the exposure cycle.
Deliverables: Acute exposure original records, individual poisoning symptom statistical data, acute muscle toxicity grading results and rapid safety screening report.
Applicable Scenarios: Combined muscular toxicity evaluation of multiple mixed pollutants or compounds. Applied to analyze the interactive toxic effects of composite water contaminants on aquatic muscle tissues.
Technical Capabilities: Design multi-group combined exposure experiments, systematically identify synergistic, antagonistic or additive muscle damage effects, and clarify the interaction mechanism of different toxins on muscle tissues.
Deliverables: Combined toxicity experimental data, toxin interaction effect analysis chart, composite muscle toxicity evaluation conclusion and mechanism summary report.
Applicable Scenarios: Long-term cumulative muscular damage research. Suitable for exploring growth retardation, muscle atrophy and persistent kinetic dysfunction caused by low-dose long-term toxin exposure in aquatic organisms.
Technical Capabilities: Carry out prolonged low-concentration continuous exposure, dynamically track muscle growth status, tissue morphology and movement ability changes, and capture delayed cumulative muscle toxicity phenotypes.
Deliverables: Long-term growth monitoring data, muscle tissue morphological statistics, cumulative toxicity trend analysis and chronic muscle damage evaluation report.
Applicable Scenarios: Immune-mediated muscle injury detection. Used to evaluate the activation or inhibition of muscle immune function induced by exogenous compounds and subsequent inflammatory muscle damage.
Technical Capabilities: Detect aquatic muscle immune cell quantity and activity changes, quantify the expression level of muscle immune and inflammatory genes, and analyze immune response-related muscular lesions.
Deliverables: Immune index quantitative data, gene expression difference analysis, immune-mediated muscle damage characteristics and toxicological evaluation report.
All testing procedures adopt BioVenic unified RUO research specifications, realizing full-process standardized control to ensure high repeatability and accuracy of muscle toxicity test data.
Evaluate the muscular toxicity hazards of environmental pollutants to aquatic populations, supporting ecological risk early warning and water environment protection research.
Screen muscle damage risks of aquaculture drugs and feed additives to ensure the healthy growth of farmed aquatic organisms.
Complete muscular safety evaluation of new pharmaceutical and chemical compounds to eliminate potential aquatic biological hidden dangers.
Explore gene-regulated muscle development and regeneration mechanisms, providing animal experimental data for muscle disease basic research.
A peer-reviewed study explored the core regulatory function of Cox7a1 in aquatic muscle physiology and cardiac regeneration. The independent academic research verified that Cox7a1-dependent complex IV dimerization maintains normal skeletal muscle development and myocardial repair capacity, and abnormal gene expression directly triggers muscle functional defects and developmental disorders.
Building on these published research foundations, BioVenic optimizes multi-index aquatic muscle toxicity detection systems. We provide comprehensive skeletal and cardiac muscle toxicity testing services for ecological and pharmaceutical toxicology research projects.
Fig 2. Explore the role of Cox7a1 in muscle physiology and heart regeneration. 2,3
BioVenic delivers dedicated Aquatic Animal Muscle Toxicity Assay Service to support aquatic toxicological research and biochemical safety evaluation. Muscle tissue is vital for aquatic animal movement, metabolism and normal growth, and is vulnerable to toxicant-induced injury and functional impairment. Our experienced technicians conduct standardized muscle toxicity testing, delivering precise phenotypic and biochemical analysis for diverse experimental designs. To discuss your specific project requirements, explore our technical capabilities, or receive a detailed quote for your study, please contact us. Our professional team helps you unlock toxic mechanisms affecting muscle tissues and add solid evidence to your research.
References
Our products and services are for research use only and cannot be used for any clinical purposes.